SavedSubscribe free
The independent voice of UK resident doctorsConferences · Journals Societies · Resources
MedicMess

The UK's first doctor-verified medical conference directory

Conferences · Journals · Societies · Research, for UK resident doctors

HomeConferencesHaematologyEHA-EBMT 9th European CAR T-cell Meeting
Haematology · Annual Conference

EHA-EBMT 9th European CAR T-cell Meeting

Organised by the European Hematology Association and EBMT
Dates4–6 Feb 2027
LocationLisbon, Portugal
Trainee€100
Abstracts14 Nov 2026
A three-day in-person European CAR T-cell meeting in Lisbon from EHA and EBMT, covering clinical, translational and operational aspects of CAR T therapy.
Next stepAbstract submissions are open
Submit abstract
Reviewed byDr Robert BaxterDr Robert Baxter· Junior Clinical Fellow, Acute Medical Unit· Updated 30 Aug 2026
At a glance
NetworkingThe in-person-only format includes coffee breaks, welcome reception, lunch and…View detail

The in-person-only format includes coffee breaks, welcome reception, lunch and poster sessions.

Research ValueRegular and late-breaker abstract/clinical case routes are available, with oral…View detail

Regular and late-breaker abstract/clinical case routes are available, with oral sessions and poster sessions visible in the programme.

Trainee RelevanceEHA Junior member / EBMT Trainee member pricing is EUR…View detail

EHA Junior member / EBMT Trainee member pricing is EUR 100 across early, regular and onsite windows.

ProgrammeSchedule and session highlights
Key Themes
Lymphomas and CLLMyelomaSolid tumoursAcute leukaemias and myeloid neoplasmsManufacturing and regulatory aspectsTranslational CAR T sciencePatient-centred CAR T careBeyond cancer and T cells
12:30
Keynote
Opening & Keynote Lecture 1keynote
13:30
Plenary
Lymphomas & CLL
15:15
Satellite symposium
Satellite Symposium 1
16:15
Oral session
Oral Session
17:30
Keynote / translational
Keynote lecture 2 & Translational Session Ikeynote
13:30
Scientific session
Scientific session
16:15
Oral session
Oral Session
18:00
Scientific session
Scientific session
13:30
Scientific session
Scientific session
16:15
Oral session
Oral Session
18:00
Scientific session
Scientific session
19:15
Networking / poster
Welcome reception & poster session
SpeakersKeynotes and featured experts
MT
Maria Themeli
Meeting chair
AR
Annalisa Ruggeri
Meeting chair
UK
Ulrike Köhl
Germany
Scientific Program Committee
CB
Chiara Bonini
Italy
Scientific Program Committee
SG
Sonia Guedán
Spain
Scientific Program Committee
NM
Núria Martínez-Cibrian
Spain
Scientific Program Committee
AB
Ali Barzabachi
Lebanon
Scientific Program Committee
JK
Jürgen Kuball
Netherlands
Scientific Program Committee
NB
Natacha Bolaños
Spain
Scientific Program Committee
SC
Solène Clavreul
France
Scientific Program Committee
HM
Hilda Mekelenkamp
Netherlands
Scientific Program Committee
MN
Mairéad Ni Chonghaile
Ireland
Scientific Program Committee
EG
Esra Gulderen
Finland
Scientific Program Committee
KY
Koray Yalcin
Türkiye
Scientific Program Committee
AbstractsOpen · 14 Nov 2026
Abstract submissions are open
Deadline: 14 November 2026
What You Can Submit
abstractclinical caselate-breakingoralposter
Submission Specifications
Authors
No limit to the number of authors
Structure
Background / Aims / Methods / Results / Summary - Conclusion
References
References are obligatory for abstracts and clinical cases
Title Limit
300 characters including spaces
Figures Tables
One simple graph/image; JPEG, TIF or GIF; max 500 KB
Character Limit
3,500 characters including spaces, punctuation and template headers
Regular Deadline
14 November 2026, 23:59 CET
Presenter Requirement
Submission commits the presenting author to attend in Lisbon and, if allocated, present in the assigned oral or poster session
Late Breaking Deadline
8 January 2027, 23:59 CET
Categories & Recommended Topics
CAR-based Cellular Therapy - Clinical
Biomarkers for CAR T efficacy and prediction models for response and toxicity
Challenges of CAR-based cellular therapy: bridging therapies, lymphodepletion and clinical indication
Clinical investigations into CAR T in oncology and other fields, including adult and paediatric indications
Management of early and late toxicities
CAR-based Cellular Therapy - Preclinical
CAR T cell manufacturing methodologies
Innovative T cell engineering, CAR designs and optimisation of CAR T cell function
Mechanistic studies of efficacy, toxicities and tumour resistance
Novel in vivo and in vitro models to evaluate CAR T cells
Clinical cases
Clinical case on multiple myeloma
Clinical case on new technologies for CAR T development
Clinical case on solid tumours
Access to CAR T
Advanced practice roles within the multidisciplinary CAR T team
Models of care and multidisciplinary collaboration in CAR T programmes
Adolescent and young adult CAR T care
Quality of life
Real-world nursing practice in CAR T-cell therapy
Symptom management and toxicity monitoring in CAR T patients
Costs & registrationTrainee tickets €100
CategoryPrice
Early bird registration€510
Standard (consultant)€675
Trainee€100
Medical student€305
Submission & registration deadlines2 tracked deadlines
Abstract deadline14 Nov 2026Checked 16 Jul 2026
Official page ↗
Registration closes3 Feb 2027Checked 16 Jul 2026
Official page ↗
Conference timeline3 key dates
14 Nov 2026
Abstract submission deadline
3 Feb 2027
Registration deadline
4 Feb 2027
Conference begins
Venue & travelCentro de Congressos de Lisboa · Lisbon
Travel NoteParticipants are responsible for their own travel and accommodation; visa letters are available after completing registration.
AccommodationSelected hotel links are provided in registration confirmation emails.
Venue DetailsCentro de Congressos de Lisboa, Praça das Indústrias 1, 1300-307 Lisbon, Portugal
MedicMess tips3 practical tips

MedicMess Tips

  • Early registration closes 9 December 2026 at 23:59 CET; regular registration closes 3 February 2027.
  • The meeting is fully in person with no livestream or virtual platform.
  • Late-breaker abstracts open 1 January 2027 and close 8 January 2027.
Complete guideFull MedicMess editorial briefing

The ninth EHA-EBMT European CAR T-cell Meeting takes place in Lisbon from 4 to 6 February 2027. It is fully in person and targets haematologists, oncologists, physicians, nurses, data managers, supply chain managers and patient-organisation representatives. The programme covers clinical successes and remaining challenges, toxicity management, long-term safety and efficacy, scientific innovation, real-world application and emerging indications. The linked programme at a glance already shows keynote, scientific, oral, poster, translational and satellite sessions across the meeting. Abstract and clinical case submission is open from 1 July 2026 with a regular deadline of 14 November 2026, notification by 1 December and a withdrawal deadline of 15 December. A late-breaker route opens on 1 January 2027 and closes on 8 January. Registration tiers are published in euros for physicians, other professionals, nurses, junior/trainee members and industry representatives, with early, regular and onsite windows. The venue is Centro de Congressos de Lisboa; livestream access is explicitly not offered.

Frequently asked
When is EHA-EBMT 9th European CAR T-cell Meeting?
EHA-EBMT 9th European CAR T-cell Meeting takes place 4–6 Feb 2027 in Centro de Congressos de Lisboa, Lisbon.
Where is EHA-EBMT 9th European CAR T-cell Meeting held?
EHA-EBMT 9th European CAR T-cell Meeting is held at Centro de Congressos de Lisboa, Lisbon, Portugal.
What is the abstract submission deadline for EHA-EBMT 9th European CAR T-cell Meeting?
Abstract submissions close on 14 Nov 2026.
When does registration close for EHA-EBMT 9th European CAR T-cell Meeting?
Registration closes on 3 Feb 2027.
How much does EHA-EBMT 9th European CAR T-cell Meeting cost?
Registration is €100 for trainees, €675 standard.
Is EHA-EBMT 9th European CAR T-cell Meeting CPD accredited?
Yes — EHA-EBMT 9th European CAR T-cell Meeting is CPD accredited.
Similar conferences

View all Haematology conferences →